Doctor Jan Walter Dhillon Shanmuganathan

Doctor Jan Walter Dhillon Shanmuganathan

Aalborg University Hospital, Aalborg (Denmark)

Member of:

Dr. Jan Walter Dhillon Shanmuganathan graduated from Aarhus University in Denmark in 2016. He is undergoing residency in Cardiology and works at Aalborg University Hospital. He is interested in research focusing on ischaemic heart disease. He is a member of European Society of Cardiology (ESC) and Danish Society of Cardiology (DSC).

Presentations

Cardiovascular events following vascular endothelial growth factor inhibitor therapy with sunitinib or pazopanib in patients with renal cell carcinoma - a nationwide registry-based follow-up study

Event: ESC Congress 2023

Topic: Cardio-Oncology

Session: Basic research in cardio-oncology

Access

Risk of myocardial infarction following capecitabine treatment in patients with gastrointestinal cancer - a nationwide registry-based study

Event: ESC Congress 2023

Topic: Epidemiology, Prognosis, Outcome

Session: Drug-related risk management in chronic coronary syndromes

Access

Higher risk of myocardial infarction in the first year following 5-fluorouracil treatment

Event: ESC Congress 2019

Topic: Pharmacotherapy

Session: New insights for acute coronary syndrome pharmacotherapy

Access

Doctor Jan Walter Dhillon Shanmuganathan

Biography

Contributor content

Cardiovascular events following vascular endothelial growth factor inhibitor therapy with sunitinib or pazopanib in patients with renal cell carcinoma - a nationwide registry-based follow-up study

Risk of myocardial infarction following capecitabine treatment in patients with gastrointestinal cancer - a nationwide registry-based study

Higher risk of myocardial infarction in the first year following 5-fluorouracil treatment

ESC 365 is supported by